SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 7.08 |
Enterprise Value ($M) | 3.37 |
Book Value ($M) | 0.62 |
Book Value / Share | 0.04 |
Price / Book | 11.51 |
NCAV ($M) | 0.62 |
NCAV / Share | 0.03 |
Price / NCAV | 11.51 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -22.93 |
Return on Assets (ROA) | -1.83 |
Return on Equity (ROE) | -3.02 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.19 |
Current Ratio | 1.19 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 3.86 |
Assets | 3.86 |
Liabilities | 3.24 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -14.10 |
Net Income | -14.10 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -10.38 |
Cash from Investing | 0.00 |
Cash from Financing | 6.62 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
15,850 | 71,297 | 22.23 | |
39,216 | 115,116 | 34.07 | |
50,123 | 156,800 | 31.97 | |
77,343 | 318,715 | 24.27 | |
50,356 | 160,625 | 31.35 | |
(click for more detail) |
Similar Companies | |
---|---|
ABVC – ABVC BioPharma, Inc. | ACB – Aurora Cannabis Inc. |
ACHV – Achieve Life Sciences, Inc. | ADIL – Adial Pharmaceuticals, Inc. |
ADTX – Aditxt, Inc. |
Financial data and stock pages provided by
Fintel.io